Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Search results for: methotrexate
Drug Updates
Information on new approvals and medication safety.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Coding Corner: Incident-To
A 65-year-old female Medicare patient with rheumatoid arthritis sees a nonphysician provider for a followup visit.
Systemic Juvenile Idiopathic Arthritis
Changing treatment paradigms in the biologic era
Coding Corner: May’s Coding Challenge
A 54-year-old female with rheumatoid arthritis is seen by the rheumatologist for a follow-up visit.
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances
Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk
Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.
Ethics Forum: The Ethical Pitfalls of Clinical Trials
Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.
- « Previous Page
- 1
- …
- 91
- 92
- 93
- 94
- 95
- …
- 107
- Next Page »